150 related articles for article (PubMed ID: 2472923)
1. C5 neoepitopes appearing during activation.
Inoue K
Complement Inflamm; 1989; 6(3):219-22. PubMed ID: 2472923
[TBL] [Abstract][Full Text] [Related]
2. Rapid and simple measurement of human C5a-des-Arg level in plasma or serum using monoclonal antibodies.
Takeda J; Kinoshita T; Takata Y; Kozono H; Tanaka E; Hong K; Inoue K
J Immunol Methods; 1987 Aug; 101(2):265-70. PubMed ID: 3611800
[TBL] [Abstract][Full Text] [Related]
3. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
Gerard C; Hugli TE
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
[TBL] [Abstract][Full Text] [Related]
4. Measurement of complement activation in rabbit plasma or serum using monoclonal antibodies against C5a.
Bergh K; Iversen OJ
Scand J Immunol; 1989 Mar; 29(3):333-41. PubMed ID: 2470136
[TBL] [Abstract][Full Text] [Related]
5. Purification of human C5a des arg by immunoadsorbent and molecular sieve chromatography.
Manderino GL; Suarez AF; Kunkel SL; Ward PA; Hirata AA; Showell H
J Immunol Methods; 1982 Aug; 53(1):41-50. PubMed ID: 6752282
[TBL] [Abstract][Full Text] [Related]
6. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
Senior RM; Griffin GL; Perez HD; Webster RO
J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381
[TBL] [Abstract][Full Text] [Related]
7. A specific enzyme-linked immunosorbent assay (ELISA) for the determination of human C5a antigen.
Kunkel SL; Manderino GL; Marasco W; Kaercher K; Hirata AA; Ward PA
J Immunol Methods; 1983 Sep; 62(3):305-14. PubMed ID: 6193199
[TBL] [Abstract][Full Text] [Related]
8. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
Marder SR; Chenoweth DE; Goldstein IM; Perez HD
J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709
[TBL] [Abstract][Full Text] [Related]
9. Eculizumab-C5 complexes express a C5a neoepitope in vivo: Consequences for interpretation of patient complement analyses.
Nilsson PH; Thomas AM; Bergseth G; Gustavsen A; Volokhina EB; van den Heuvel LP; Barratt-Due A; Mollnes TE
Mol Immunol; 2017 Sep; 89():111-114. PubMed ID: 28610663
[TBL] [Abstract][Full Text] [Related]
10. Biological properties of human C5a: selected in vitro and in vivo studies.
Yancey KB
Clin Exp Immunol; 1988 Feb; 71(2):207-10. PubMed ID: 3280183
[No Abstract] [Full Text] [Related]
11. The C5a receptor of neutrophils and macrophages.
Chenoweth DE; Goodman MG
Agents Actions Suppl; 1983; 12():252-73. PubMed ID: 6573117
[No Abstract] [Full Text] [Related]
12. Amino-acid sequence and disulfide linkages of the anaphylatoxin, des-Arg omega-C5a, from porcine serum.
Zimmermann B; Vogt W
Hoppe Seylers Z Physiol Chem; 1984 Feb; 365(2):151-8. PubMed ID: 6714942
[TBL] [Abstract][Full Text] [Related]
13. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
Perez HD; Chenoweth DE; Goldstein IM
J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
[TBL] [Abstract][Full Text] [Related]
14. Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitope-specific sandwich-ELISA for the quantification of C5a des Arg in plasma.
Bergh K; Iversen OJ
J Immunol Methods; 1992 Jul; 152(1):79-87. PubMed ID: 1379278
[TBL] [Abstract][Full Text] [Related]
15. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome.
Weinberg PF; Matthay MA; Webster RO; Roskos KV; Goldstein IM; Murray JF
Am Rev Respir Dis; 1984 Nov; 130(5):791-6. PubMed ID: 6497161
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: flow cytometric and chemotaxis studies.
Yancey KB; Lawley TJ; Dersookian M; Harvath L
J Invest Dermatol; 1989 Feb; 92(2):184-9. PubMed ID: 2493055
[TBL] [Abstract][Full Text] [Related]
17. Characterization of murine monoclonal antibodies that recognize neutralizing epitopes on human C5a.
Larrick JW; Wang J; Fendly BM; Chenoweth DE; Kunkel SL; Deinhart T
Infect Immun; 1987 Aug; 55(8):1867-72. PubMed ID: 2440808
[TBL] [Abstract][Full Text] [Related]
18. The chemoattractant des-Arg74-C5a regulates the expression of its own receptor on a monocyte-like cell line.
Barker MD; Jose PJ; Williams TJ; Burton DR
Biochem J; 1986 Jun; 236(2):621-4. PubMed ID: 3019322
[TBL] [Abstract][Full Text] [Related]
19. Airways hyperreactivity and inflammation produced by aerosolization of human C5A des arg.
Irvin CG; Berend N; Henson PM
Am Rev Respir Dis; 1986 Oct; 134(4):777-83. PubMed ID: 3767132
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory properties of human C5a and C5a des Arg/ in mast cell-depleted human skin.
Swerlick RA; Yancey KB; Lawley TJ
J Invest Dermatol; 1989 Sep; 93(3):417-22. PubMed ID: 2527912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
